Abstract Minor amounts of glucose incorporated into the cells is metabolized via the hexosamine biosynthetic pathway, resulting in the production of uridine-5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc), which is utilized as a donor substrate for the N-and O-linked glycosylation of extracellular and membrane proteins in the Golgi apparatus, or for the O-linked GlcNAc modification (O-GlcNAcylation) of intracellular proteins in the cytosol. In particular, O-GlcNAcylation, the addition of GlcNAc to serine/threonine residues, is reversibly regulated by the enzymatic activities of O-GlcNAc transferase (OGT) and O-GlcNAcase. Since OGT activity is sensitive to the intracellular UDP-GlcNAc level, flux via the hexosamine pathway influences O-GlcNAcylation. Actually, excess flux via the hexosamine pathway and resultant increased O-GlcNAcylation are associated with several pathophysiological conditions, including insulin resistance. To date, there are several studies addressing the effects of exercise on the hexosamine pathway and O-GlcNAcylation. Thus, this short review focuses on the relationships among exercise, the hexosamine pathway, O-GlcNAcylation, and insulin resistance.
Introduction
Glucose is incorporated into the cells via glucose transporter (GLUT), and is initially converted to glucose-6-phosphate by hexokinase ( Fig. 1 ) 1) . Approximately 1-3% of the glucose-6-phosphate is metabolized via the hexosamine biosynthetic pathway after conversion to fructose-6-phosphate 2) , although the majority of the incorporated glucose is metabolized by glycolysis and is utilized as an energy source to produce ATP ( Fig. 1) 1) . In the hexosamine biosynthetic pathway, the fructose-6-phosphate is first converted to glucosamine-6-phosphate by glutamine:fructose-6-phosphate amidotransferase (GFAT), the rate-limiting enzyme of the hexosamine biosynthetic pathway; and the glucosamine-6-phosphate is then acetylated by glucosamine-6-phosphate N-acetyltransferase (GNA) to form N-acetylglucosamine (GlcNAc)-6-phosphate, which is isomerized to GlcNAc-1-phosphate and uridinylated by the action of uridine-5'-diphosphate (UDP)-GlcNAc pyrophosphorylase (UAP) (Fig. 1) 1) . The synthesized UDP-GlcNAc is partially transported into the Golgi apparatus via the UDP-GlcNAc transporter 3) , and is then utilized as a donor substrate for the N-linked glycosylation (N-glycosylation) and O-linked glycosylation of extracellular and membrane proteins; alternatively, it is also utilized in the cytosol for the O-linked GlcNAc (OGlcNAc) modification (O-GlcNAcylation) of intracellular proteins ( Fig. 1) 1) . Recently, it was reported that regular exercise training modulates the hexosamine biosynthetic pathway and O-GlcNAcylation 4) . However, the relationships among exercise, the hexosamine biosynthetic pathway, and glycosylation as well as their physiological significances still remain unclear. In this short review, therefore, the authors discuss this unknown area focusing mainly on the relationships among exercise, the hexosamine biosynthetic pathway, O-GlcNAcylation, and insulin resistance.
N-glycosylation
Glycosylation, one of the most abundant posttranslational modification reactions, is necessary for protein stability, as well as the localization and trafficking of proteins. Approximately 50% of proteins in mammalian cells are modified with a variety of glycans, which are classified into two major groups, N-and O-glycans 5) . N-glycans are attached to certain asparagine residues of proteins with the Asn-X-Ser/Thr motif, whereas O-glycans are attached to a subset of serine and threonine residues 6) . The addition of GlcNAc from UDP-GlcNAc to N-and O-glycans is catalyzed by enzymatic activity of various types of GlcNAc transferase (GnT) localized in the Golgi appa- ratus. The formation of branched structures and resultant elongation and processing of N-glycans by GnT modulate the physiological functions of the glycoproteins 7) , and are associated with a variety of disorders, such as cancer and diabetes mellitus 8, 9) . Among different types of GnT, GnT-V catalyzes the transfer of a single GlcNAc from UDP-GlcNAc to a α1,6-mannose in N-glycans to form a β1,6-branched N-glycans (Fig. 2) , and this leads to elongation of the polylactosamine structure, which controls the cell surface residency of receptors and is associated with some of the invasive characteristics of cancer cells 5, 10, 11) . The overexpression of GnT-V inhibits clustering of integrin α5β1, indicating that this mediates reduced adhesion and increased motility of cancer cells 12) . Indeed, enhanced GnT-V activity and elevated β1,6-branched N-glycan levels are observed in highly metastatic cancer cell lines 13, 14) . In addition, GnT-IV catalyzes the transfer of a single GlcNAc from UDP-GlcNAc to a α1,3-mannose in Nglycans to form a β1,4 GlcNAc branch (Fig. 2) . A loss of GnT-IVa attenuates the half-life of GLUT2 on the pancreatic β-cell surface, and resultant impairment of glucose-stimulated insulin secretion leads to metabolic dysfunctions that are characteristics of type 2 diabetes 15) . Furthermore, chronic high-fat diet feeding of mice reduces the expression and nuclear localization of the transcription factors, forkhead box protein A2 (FOXA2) and hepatocyte nuclear factor 1 homeobox A (HNF1A), resulting in a deficiency of GnT-IVa expression in the pancreatic β-cells, and such a pathogenic process is observed also in human islet cells from patients with type 2 diabetes 16) . On the contrary, GnT-III catalyzes the transfer of a single GlcNAc from UDP-GlcNAc in a β1,4-linkage to the mannose residue at the base of the trimannosyl core in N-glycans to form a so-called "bisecting GlcNAc" 17,18) (Fig. 2) . The introduction of a bisecting GlcNAc prevents the formation of branched structures in N-glycans, because other GnT are not able to utilize an N-glycan with a bisecting GlcNAc as an acceptor substrate 19) . Actually, the overexpression of GnT-III blocks integrin α3β1-mediated cell migration on laminin 5 in GnT-V transfectant. Conversely, the knockdown of GnT-III increases cell migration as well as β1,6-branched N-glycan levels on integrin α3 subunit 20) . In particular, the intracellular UDP-GlcNAc level modulates N-glycosylation patterns, because GnT have different Km values for UDP-GlcNAc 21) . Among the different types of GnT, GnT-V and GnT-IV have much higher Km values, and their enzymatic activities are enhanced in response to increased intracellular UDP-GlcNAc levels 22) . In fact, β1,6-branched N-glycan levels in Jurkat T-cells are elevated by supplementation of metabolic precursors of the hexosamine biosynthetic pathway, which regulates autoimmunity reactions of T-cells 23) . Thus, glycosylation is affected not only by the levels of expression of a single GnT enzyme, but also by a variety of other factors, including flux via the hexosamine biosynthetic pathway 10) .
O-GlcNAcylation
O-GlcNAcylation is a highly reversible, inducible and dynamic post-translational modification, which mediates the addition of GlcNAc from UDP-GlcNAc to serine and/ or threonine residues of cytosolic and nuclear proteins 24) . To date, more than 600 proteins have been identified as substrate proteins for O-GlcNAcylation, and are associated with a variety of cellular processes, including cell proliferation, transcription, signal transduction, and metabolism 24) . This modification is reversibly regulated by the enzymatic activity of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) (Fig. 3) . OGT catalyzes the . Approximately 1-3% of the incorporated glucose is metabolized via the hexosamine biosynthetic pathway 2) , and this leads to the production of UDP-GlcNAc, which is utilized in the Golgi apparatus as a donor substrate for N-and O-glycosylation of extracellular and membrane proteins. Alternatively, it is utilized in the cytosol as a donor substrate for O-GlcNAcylation of cytosolic and nuclear proteins. GLUT, glucose transporter; Glc, glucose; P, phosphate; Fruc, fructose; GlcN, glucosamine; GlcNAc, N-acetylglucosamine; UDP, uridine-5'-diphosphate; UTP, uridine-5'-triphosphate; GFAT, glutamine:Fruc-6-P amidotransferase; GNA, GlcN-6-P N-acetyltransferase; UAP, UDP-GlcNAc pyrophosphorylase; GnT, GlcNAc transferase; OGT, O-linked GnT. levels, indicating that cross-talk between adipocytes and skeletal muscle cells contributes to the development of whole body insulin resistance 32) . In contrast, transgenic mice overexpressing GLUT1 in skeletal muscle show impaired insulin-stimulated glucose transport activity in skeletal muscle 37) . The discrepancy in results between GFAT and GLUT1 transgenic mouse models indicates that the hyperglycemia-induced impairment of insulinstimulated glucose uptake is mediated by increased flux via the hexosamine biosynthetic pathway as well as other mechanisms 24, 38) , such as accumulation of excess glycogen contents in skeletal muscle 34, 39) . Since O-GlcNAcylation is abundantly identified on signaling proteins, including insulin signaling, and antagonizes O-phosphorylation of certain proteins, such as insulin receptor substrate 1 (IRS-1), it is also suggested that accumulation of UDP-GlcNAc, the end product of the hexosamine biosynthetic pathway, mediates the development of insulin resistance partially via elevating OGlcNAc levels on such signaling proteins 24) . In fact, transgenic mice overexpressing OGT in adipose tissue and striated muscle show decreased insulin-stimulated wholebody glucose disposal, and hyperinsulinemia and hyperleptinemia 40) , which are consistent with the phenotypes observed in GFAT transgenic mice 32, 35, 36) . Furthermore, insulin stimulation recruits OGT from the nucleus to the plasma membrane, wherein OGT catalyzes O-GlcNAcylation on some insulin signaling proteins and attenuates its signal transduction by altering their phosphorylation status, and hepatic overexpression of OGT impairs the transcription of insulin-responsive genes and causes the perturbation of insulin-induced inhibition of gluconeotransfer of a single GlcNAc from UDP-GlcNAc to serine/threonine residues of substrate proteins 25, 26) ; whereas OGA catalyzes the removal of the GlcNAc from such residues 27, 28) . Since the affinity of OGT for substrate proteins is highly sensitive to the intracellular UDP-GlcNAc level 29) , glucose flux via the hexosamine biosynthetic pathway directly influences O-GlcNAc levels. Indeed, hyperglycemia 30) , glucosamine infusion 30) , GLUT overexpression 31) , and GFAT overexpression 32) , all of which increase flux via the hexosamine biosynthetic pathway, result in increased intracellular UDP-GlcNAc and OGlcNAc levels.
It is suggested that excess flux via the hexosamine biosynthetic pathway in adipocytes is one mechanism for the development of insulin resistance. Actually, irreversible inactivation of glutamine-requiring enzymes, including GFAT, by treatment with glutamine analogues improves hyperglycemia-induced desensitization of insulin-stimulated glucose uptake in rat primary adipocytes 33) , but not in isolated rat skeletal muscle 34) . In addition, the overexpression of GFAT in the skeletal muscle and adipose tissue of transgenic mice leads to insulin resistant phenotypes, characterized by reductions in the whole body glucose disposal rate, glucose uptake in skeletal muscle, and GLUT4 translocation in response to insulin stimulation 35, 36) . However, insulin-stimulated glucose uptake in isolated skeletal muscle microexplant cultures of transgenic mice is similar to that of wild-type mice, although transgenic mice overexpressing GFAT, specifically in adipose tissue, display decreased insulin-stimulated glucose uptake in skeletal muscle and reduced serum adiponectin GnT-IV Fig. 2 N-glycosylation catalyzed by the actions of GnT-V, GnT-IV, and GnT-III. The enzymatic products of GnT-V, GnT-IV, and GnT-III are designated as β1,6 GlcNAc branch linked to α1,6 mannose, β1,4 GlcNAc branch linked to α1,3 mannose, and bisecting GlcNAc, respectively. The introduction of a bisecting GlcNAc prevents the formation of GlcNAc branches 19) . The activity of GnT-V and GnT-IV is highly sensitive to the intracellular UDPGlcNAc level 22) . GlcNAc, N-acetylglucosamine; GnT, GlcNAc transferase; Asn, asparagine.
Fig. 3 O-GlcNAcylation catalyzed by the actions of OGT and
OGA. OGT catalyzes the transfer of a single GlcNAc from UDP-GlcNAc to serine/threonine residues of substrate proteins 25, 26) , while OGA catalyzes the removal of the GlcNAc from such residues 27, 28) . The affinity of OGT for substrate proteins is highly sensitive to the intracellular UDP-GlcNAc level 29) . 
OGA
of GFAT is not affected. Thus, it is concluded that the hexosamine biosynthetic pathway is not involved in the exercise-stimulated glucose uptake in skeletal muscle 47) . However, it still remains unclear how exercise affects OGlcNAc levels on signaling proteins and transcription factors downstream of the insulin receptor, and expression levels or enzymatic activities of OGT and OGA in the skeletal muscle. In addition, it is also unclear whether exercise affects the hexosamine biosynthetic pathway and O-GlcNAcylation in obese and diabetic animals with increased glucose flux via the hexosamine biosynthetic pathway.
Furthermore, it is of critical importance to clarify the effects of different types and doses of exercise on the hexosamine biosynthetic pathway and glycosylation. Actually, a more recent study by Belke 4) demonstrated that regular swim exercise training in mice decreases OGlcNAc levels on cardiac proteins, including the transcription factor, specificity protein 1 (Sp1), accompanied by reduced expression levels of GFAT2, OGT, and OGA, some of which are shown not to be affected by an acute bout of swim exercise 47) . These results strongly suggest genesis 41) . On the other hand, pharmacological approaches are carried out to address whether the inhibition of OGA enzymatic activity and resultant elevated O-GlcNAc levels lead to the development of insulin resistance. Competitive inhibition of OGA glycosidase activity using a GlcNAc analogue O-(2-acetoamido-2 deoxy-Dglucopyranosylidene)-amino-N-phenylcaramate (PUGNAc) results in elevation of global O-GlcNAc levels, and suppresses insulin-stimulated glucose uptake and Akt phosphorylation in 3T3-L1 adipocytes 42) . However, such insulin-desensitizing effects are not observed when 3T3-L1 adipocytes are treated with 1,2-dideoxy-2'-propyl-α-D-glucopyranoso-[2,1-D]-Δ2'-thiazoline (NButGT), a more potent and selective OGA inhibitor 43) , and similar results were also obtained in a rodent model 44) , indicating that non-targeted globally elevated O-GlcNAc levels do not independently cause the development of insulin resistance 43, 44) . In contrast, several genetic and epidemiological approaches imply that OGA enzymatic activity is associated with the development of insulin resistance. An animal experiment using high-fat diet-fed mice and genetically obese and insulin-resistant db/db mice demonstrates that hepatic overexpression of OGA ameliorates the elevated plasma glucose level and promotes O-GlcNAc removal from the transducer of regulated cyclic adenosine monophosphate response element-binding protein (CREB) 2 (CRTC2), indicating that OGA improves glucose tolerance and insulin sensitivity via the reduction of OGlcNAc levels on the insulin signaling protein 45) . In addition, a single nucleotide polymorphism (SNP) of the human MGEA5 gene, encoding OGA, is suggested to be a potential risk factor for type 2 diabetes in Mexican Americans 46) .
Exercise, the hexosamine biosynthetic pathway, and glycosylation
Little is known so far how exercise affects the hexosamine biosynthetic pathway and glycosylation, and whether the ameliorating and preventive effects of exercise on a variety of pathophysiological processes, including insulin resistance, are mediated via modulating the metabolic pathway and glycosylation. Nelson et al. 47) conducted the first study to address whether exercise reduces glucose flux via the hexosamine biosynthetic pathway and mediates exercise-stimulated glucose uptake in hindlimb skeletal muscle. They demonstrated that an acute bout of swim exercise with high intensity significantly increases UDP-N-acetylhexosamine (HexNAc) levels postexercise in hindlimb skeletal muscle in ad libitum fed rats but not in fasted rats 47) . In addition, an in vitro assay using extracts from hindlimb skeletal muscle revealed that this type of exercise does not change the enzymatic activity of GFAT 47) , indicating that the expression level 23 An acute bout of swim exercise increases UDP-HexNAc levels post-exercise in hindlimb skeletal muscle in ad libitum fed rats, without changing GFAT expression levels 47) , although it is unclear how the exercise influences O-GlcNAcylation. The effects of an acute swim exercise on the hexosamine biosynthetic pathway and O-GlcNAcylation in adipose tissue and liver are not reported 48) . On the other hand, regular swim exercise training decreases the levels of GFAT, OGT, OGA, and O-GlcNAc in heart in mice 4) . However, the effects of regular swim exercise training on the hexosamine biosynthetic pathway and O-GlcNAcylation in skeletal muscle, adipose tissue, and liver are not reported. GFAT, glutamine:fructose-6-phosphate amidotransferase; UDP, uridine-5'-diphosphate; HexNAc, N-
that the reduced biosynthetic activity of UDP-GlcNAc and the attenuated enzymatic activity for the O-GlcNAcylation cycle in response to regular exercise training synergistically lead to the decreased O-GlcNAc levels in the heart. Thus, it is interesting to address systematically the effects of regular excise training on flux via the hexosamine biosynthetic pathway and O-GlcNAc levels in skeletal muscle, adipose tissue, and liver, all of which are important sites to develop insulin resistance 48) . Indeed, increased responsiveness to insulin stimulation via the IRS/ phosphoinositide 3-kinase (PI3K)/Akt O-phosphorylation signaling pathway is observed in adipocytes isolated from endurance exercise-trained rats 49) . The insulin-stimulated translocation of OGT from the nucleus to the plasma membrane and subsequent O-GlcNAcylation of IRS-1 is a negative-feedback regulatory mechanism for insulin signaling 41) , and elevated O-GlcNAc levels in 3T3-L1 adipocytes inhibit phosphorylation of Tyr 608 -X-X-Met, a PI3K p85 subunit binding motif, in IRS-1 and results in reduced insulin signaling 50) . On the other hand, treadmill exercise-stimulated plasma glucose clearance is impaired by glucosamine infusion 51) , indicating a possible link between exercise and the hexosamine biosynthetic pathway.
Conclusion
The findings obtained to date on the effects of exercise on the hexosamine biosynthetic pathway and O-GlcNAcylation are summarized in Fig. 4 . As illustrated in the figure, there are still a lot of unclear points. It is also interesting to address how exercise modulates other types of glycosylation, including N-glycosylation. The elucidation of these unclear points may lead to further understanding of molecular mechanisms of the ameliorating and preventive effects of exercise on a variety of pathophysiological processes, including insulin resistance. 
